Innate immunity via Toll-like receptors and Nod proteins

Current Opinion in Microbiology

Volumn 7, Issue 1, 2004, Pages 25-32

  Athman, Rafika ^a   Philpott, Dana ^a  

^a INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; CASPASE ACTIVATING AND RECRUITMENT DOMAIN 4 PROTEIN; CASPASE RECRUITMENT DOMAIN PROTEIN 15; MEMBRANE PROTEIN; MYELOID DIFFERENTIATION FACTOR 88; NUCLEOTIDE BINDING PROTEIN; PEPTIDOGLYCAN; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 10; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 6; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; TOLL LIKE RECEPTOR 9; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; BACTERICIDAL ACTIVITY; CARBOXY TERMINAL SEQUENCE; CELLULAR IMMUNITY; CROHN DISEASE; CYTOKINE PRODUCTION; ENZYME RELEASE; EPITHELIUM CELL; GENE MUTATION; GRAM NEGATIVE BACTERIUM; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; INTERNALIZATION; MICROBIAL IMMUNITY; NONHUMAN; NUCLEOTIDE BINDING SITE; OLIGOMERIZATION; PHAGOCYTOSIS; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; REVIEW; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION; TISSUE DISTRIBUTION;

BACTERIA (MICROORGANISMS); NEGIBACTERIA;

EID: 1242284156     PISSN: 13695274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mib.2003.12.013     Document Type: Review

References (56)

1. Matzinger P. The danger model: a renewed sense of self. Science. 296:2002;301-305.
2. Vabulas R.M., Wagner H., Schild H. Heat shock proteins as ligands of toll-like receptors. Curr. Top Microbiol. Immunol. 270:2002;169-184.
3. Guillot L., Balloy V., McCormack F.X., Golenbock D.T., Chignard M., Si-Tahar M. Cutting edge: the immunostimulatory activity of the lung surfactant protein-A involves Toll-like receptor 4. J. Immunol. 168:2002;5989-5992.
4. Termeer C., Benedix F., Sleeman J., Fieber C., Voith U., Ahrens T., Miyake K., Freudenberg M., Galanos C., Simon J.C. Oligosaccharides of Hyaluronan activate dendritic cells via toll-like receptor 4. J. Exp. Med. 195:2002;99-111.
5. Biragyn A., Ruffini P.A., Leifer C.A., Klyushnenkova E., Shakhov A., Chertov O., Shirakawa A.K., Farber J.M., Segal D.M., Oppenheim J.J.et al. Toll-like receptor 4-dependent activation of dendritic cells by beta-defensin 2. Science. 298:2002;1025-1029.
6. Backhed F., Rokbi B., Torstensson E., Zhao Y., Nilsson C., Seguin D., Normark S., Buchan A.M., Richter-Dahlfors A. Gastric mucosal recognition of Helicobacter pylori is independent of Toll-like receptor 4. J. Infect Dis. 187:2003;829-836.
7. Abreu M.T., Vora P., Faure E., Thomas L.S., Arnold E.T., Arditi M. Decreased expression of Toll-like receptor-4 and MD-2 correlates with intestinal epithelial cell protection against dysregulated proinflammatory gene expression in response to bacterial lipopolysaccharide. J. Immunol. 167:2001;1609-1616.
8. Gewirtz A.T., Navas T.A., Lyons S., Godowski P.J., Madara J.L. Cutting edge: bacterial flagellin activates basolaterally expressed TLR5 to induce epithelial proinflammatory gene expression. J. Immunol. 167:2001;1882-1885.
9. Cario E., Brown D., McKee M., Lynch-Devaney K., Gerken G., Podolsky D.K. Commensal-associated molecular patterns induce selective toll-like receptor-trafficking from apical membrane to cytoplasmic compartments in polarized intestinal epithelium. Am. J. Pathol. 160:2002;165-173.
10. Hornef M.W., Frisan T., Vandewalle A., Normark S., Richter-Dahlfors A. Toll-like receptor 4 resides in the Golgi apparatus and colocalizes with internalized lipopolysaccharide in intestinal epithelial cells. J. Exp. Med. 195:2002;559-570.
11. Hornef M.W., Normark B.H., Vandewalle A., Normark S. Intracellular recognition of lipopolysaccharide by toll-like receptor 4 in intestinal epithelial cells. J. Exp. Med. 198:2003;1225-1235.
12. Guillot L, Medjane S, Le-Barillec K, Balloy V, Danel C, Chignard M, Si-Tahar M: Response of human pulmonary epithelial cells to LPS involves toll-like receptor 4 (TLR4)-dependent signaling pathways: evidence for an intracellular compartmentalization of TLR4. J Biol Chem 2003, in press.
13. Huang Q., Liu D., Majewski P., Schulte L.C., Korn J.M., Young R.A., Lander E.S., Hacohen N. The plasticity of dendritic cell responses to pathogens and their components. Science. 294:2001;870-875.
14. Toshchakov V., Jones B.W., Perera P.Y., Thomas K., Cody M.J., Zhang S., Williams B.R., Major J., Hamilton T.A., Fenton M.J.et al. TLR4, but not TLR2, mediates IFN-beta-induced STAT1alpha/beta-dependent gene expression in macrophages. Nat Immunol. 3:2002;392-398.
15. Takeda K., Kaisho T., Akira S. Toll-like receptors. Annu. Rev. Immunol. 21:2003;335-376.
16. Suzuki N., Suzuki S., Duncan G.S., Millar D.G., Wada T., Mirtsos C., Takada H., Wakeham A., Itie A., Li S.et al. Severe impairment of interleukin-1 and Toll-like receptor signalling in mice lacking IRAK-4. Nature. 416:2002;750-756.
17. Picard C., Puel A., Bonnet M., Ku C.L., Bustamante J., Yang K., Soudais C., Dupuis S., Feinberg J., Fieschi C.et al. Pyogenic bacterial infections in humans with IRAK-4 deficiency. Science. 299:2003;2076-2079 This report places interleukin-1 receptor-associated kinase 4 (IRAK4) as a key player in the signal transduction leading to nuclear factor-kappaB activation, showing that IRAK4-deficient patients fail to induce a proinflammatory response after ligand stimulation.
18. Medvedev A.E., Lentschat A., Kuhns D.B., Blanco J.C., Salkowski C., Zhang S., Arditi M., Gallin J.I., Vogel S.N. Distinct mutations in IRAK-4 confer hyporesponsiveness to lipopolysaccharide and interleukin-1 in a patient with recurrent bacterial infections. J. Exp. Med. 198:2003;521-531 Confirming the pivotal role of IRAK4 in the inflammatory response.
19. Kawai T., Adachi O., Ogawa T., Takeda K., Akira S. Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity. 11:1999;115-122.
20. Horng T., Barton G.M., Medzhitov R. TIRAP: an adapter molecule in the Toll signaling pathway. Nat. Immunol. 2:2001;835-841.
21. Fitzgerald K.A., Palsson-McDermott E.M., Bowie A.G., Jefferies C.A., Mansell A.S., Brady G., Brint E., Dunne A., Gray P., Harte M.T.et al. Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction. Nature. 413:2001;78-83.
22. Yamamoto M., Sato S., Hemmi H., Sanjo H., Uematsu S., Kaisho T., Hoshino K., Takeuchi O., Kobayashi M., Fujita T.et al. Essential role for TIRAP in activation of the signalling cascade shared by TLR2 and TLR4. Nature. 420:2002;324-329.
23. Horng T., Barton G.M., Flavell R.A., Medzhitov R. The adaptor molecule TIRAP provides signalling specificity for Toll-like receptors. Nature. 420:2002;329-333.
24. Yamamoto M., Sato S., Hemmi H., Hoshino K., Kaisho T., Sanjo H., Takeuchi O., Sugiyama M., Okabe M., Takeda K.et al. Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway. Science. 301:2003;640-643 This paper shows that TRIF (TIR domain-containing adaptor inducing IFN-beta) is essential for TLR3- and TLR4-mediated signaling pathways.
25. Oshiumi H., Matsumoto M., Funami K., Akazawa T., Seya T. TICAM-1, an adaptor molecule that participates in Toll-like receptor 3-mediated interferon-beta induction. Nat. Immunol. 4:2003;161-167 The authors identified an alternative adaptor, designated TICAM (Toll-interleukin 1 receptor domain-containing adaptor molecule 1) and define a TICAM-1-dependent pathway that forms part of the MyD88-independent cellular immune response.
26. Hoebe K., Du X., Georgel P., Janssen E., Tabeta K., Kim S.O., Goode J., Lin P., Mann N., Mudd S.et al. Identification of Lps2 as a key transducer of MyD88-independent TIR signalling. Nature. 424:2003;743-748 Using a forward genetic screening approach, this paper reports the identification of a frameshift mutation (Lps2) in the adaptor Tir, known as TRIF or TICAM-1 and shows that Trif(Lps2) homozygotes are resistant to the toxic effects of lipopolysaccharide (LPS). This study shows the requirement of an additional adaptor in the LPS-induced MyD88-dependent pathway.
27. Yamamoto M., Sato S., Hemmi H., Uematsu S., Hoshino K., Kaisho T., Takeuchi O., Takeda K., Akira S. TRAM is specifically involved in the Toll-like receptor 4-mediated MyD88-independent signaling pathway. Nat Immunol. 4:2003;1144-1150 The authors identified a fourth TIR domain-containing adaptor, TRIF-related adaptor molecule (TRAM). They show that TRAM provides specificity for the MyD88-independent component of TLR4 signaling.
28. Fitzgerald K.A., Rowe D.C., Barnes B.J., Caffrey D.R., Visintin A., Latz E., Monks B., Pitha P.M., Golenbock D.T. LPS-TLR4 signaling to IRF-3/7 and NF-kappaB involves the toll adapters TRAM and TRIF. J. Exp. Med. 198:2003;1043-1055.
29. Oshiumi H, Sasai M, Shida K, Fujita T, Matsumoto M, Seya T: TICACM-2: a bridging adapter recruiting to Toll-like receptor 4 TICAM-1 that induces interferon-beta. J Biol Chem 2003, in press.
30. Chamaillard M., Girardin S.E., Viala J., Philpott D.J. Nods, Nalps and Naip: intracellular regulators of bacterial-induced inflammation. Cell. Microbiol. 5:2003;581-592.
31. Inohara N., Nunez G. NODs: intracellular proteins involved in inflammation and apoptosis. Nat. Rev. Immunol. 3:2003;371-382.
32. Girardin S.E., Boneca I.G., Carneiro L.A., Antignac A., Jehanno M., Viala J., Tedin K., Taha M.K., Labigne A., Zathringer U.et al. Nod1 detects a unique muropeptide from Gram-negative bacterial peptidoglycan. Science. 300:2003;1584-1587 This paper reports that human Nod1 specifically detects a unique tripeptide motif found in Gram-negative bacterial peptidoglycan, resulting in activation of the transcription factor nuclear factor-kappaB pathway.
33. Chamaillard M., Hashimoto M., Horie Y., Masumoto J., Qiu S., Saab L., Ogura Y., Kawasaki A., Fukase K., Kusumoto S.et al. An essential role for NOD1 in host recognition of bacterial peptidoglycan containing diaminopimelic acid. Nat. Immunol. 4:2003;702-707 This study reports that NOD1 primarily mediates the recognition of Gram-negative bacteria derived peptidoglycan. Biochemical and functional analyses show that the core structure recognized by NOD1 is a dipeptide, gamma-D-glutamyl-meso-diaminopimelic acid (iE-DAP). NOD1 mediates selective recognition of bacteria through detection of iE-DAP-containing peptidoglycan.
34. Girardin S.E., Travassos L.H., Herve M., Blanot D., Boneca I.G., Philpott D.J., Sansonetti P.J., Mengin-Lecreulx D. Peptidoglycan molecular requirements allowing detection by Nod1 and Nod2. J. Biol. Chem. 278:2003;41702-41708.
35. Ogura Y., Inohara N., Benito A., Chen F.F., Yamaoka S., Nunez G. Nod2, a Nod1/Apaf-1 family member that is restricted to monocytes and activates NF-kappaB. J. Biol. Chem. 276:2001;4812-4818.
36. Girardin S.E., Boneca I.G., Viala J., Chamaillard M., Labigne A., Thomas G., Philpott D.J., Sansonetti P.J. Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. J. Biol. Chem. 278:2003;8869-8872 This study shows that Nod2 is a general sensor of peptidoglycan through the recognition of muramyl dipeptide and that the most frequent Nod2 variant associated with Crohn's disease patients abrogates Nod2-dependent detection.
37. Inohara N., Ogura Y., Fontalba A., Gutierrez O., Pons F., Crespo J., Fukase K., Inamura S., Kusumoto S., Hashimoto M.et al. Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn's disease. J. Biol. Chem. 278:2003;5509-5512 This paper reports that muramyl dipeptide derived from peptidoglycan is the essential structure in bacteria recognized by NOD2, a recognition process that could be important for protection against Crohn's disease.
38. Nau G.J., Richmond J.F., Schlesinger A., Jennings E.G., Lander E.S., Young R.A. Human macrophage activation programs induced by bacterial pathogens. Proc. Natl. Acad. Sci. USA. 99:2002;1503-1508.
39. Hugot J.P., Chamaillard M., Zouali H., Lesage S., Cezard J.P., Belaiche J., Almer S., Tysk C., O'Morain C.A., Gassull M.et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature. 411:2001;599-603.
40. Ogura Y., Bonen D.K., Inohara N., Nicolae D.L., Chen F.F., Ramos R., Britton H., Moran T., Karaliuskas R., Duerr R.H.et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature. 411:2001;603-606.
41. Chamaillard M., Philpott D.J., Girardin S.E., Zouali H., Lesage S., Chareyre F., Bui T.H., Giovannini M., Zaehringer U., Penard-Lacronique V.et al. Gene-environment interaction modulated by allelic heterogeneity in inflammatory diseases. Proc. Natl. Acad. Sci. USA. 100:2003;3455-3460.
42. Gottar M., Gobert V., Michel T., Belvin M., Duyk G., Hoffmann J.A., Ferrandon D., Royet J. The Drosophila immune response against Gram-negative bacteria is mediated by a peptidoglycan recognition protein. Nature. 416:2002;640-644.
43. Michel T., Reichhart J.M., Hoffmann J.A., Royet J. Drosophila Toll is activated by Gram-positive bacteria through a circulating peptidoglycan recognition protein. Nature. 414:2001;756-759.
44. Choe K.M., Werner T., Stoven S., Hultmark D., Anderson K.V. Requirement for a peptidoglycan recognition protein (PGRP) in Relish activation and antibacterial immune responses in Drosophila. Science. 296:2002;359-362.
45. Ramet M., Manfruelli P., Pearson A., Mathey-Prevot B., Ezekowitz R.A. Functional genomic analysis of phagocytosis and identification of a Drosophila receptor for E. coli. Nature. 416:2002;644-648.
46. Leulier F., Parquet C., Pili-Floury S., Ryu J.H., Caroff M., Lee W.J., Mengin-Lecreulx D., Lemaitre B. The Drosophila immune system detects bacteria through specific peptidoglycan recognition. Nat. Immunol. 4:2003;478-484 The Toll pathway in Drosophila is required for defense responses against Gram-positive bacteria, whereas the Imd pathway is triggered by Gram-negative bacterial infection. In this paper, the authors show that the ability of the fly to discriminate between these types of bacteria is through the recognition of specific forms of peptidoglycan.
47. Kobayashi K., Inohara N., Hernandez L.D., Galan J.E., Nunez G., Janeway C.A., Medzhitov R., Flavell R.A. RICK/Rip2/CARDIAK mediates signalling for receptors of the innate and adaptive immune systems. Nature. 416:2002;194-199.
48. Inohara N., Koseki T., Lin J., del Peso L., Lucas P.C., Chen F.F., Ogura Y., Nunez G. An induced proximity model for NF-kappa B activation in the Nod1/RICK and RIP signaling pathways. J. Biol. Chem. 275:2000;27823-27831.
49. Girardin S.E., Tournebize R., Mavris M., Page A.L., Li X., Stark G.R., Bertin J., DiStefano P.S., Yaniv M., Sansonetti P.J.et al. CARD4/Nod1 mediates NF-kappaB and JNK activation by invasive Shigella flexneri. EMBO Rep. 2:2001;736-742.
50. Inohara N., Koseki T., del Peso L., Hu Y., Yee C., Chen S., Carrio R., Merino J., Liu D., Ni J.et al. Nod1, an Apaf-1-like activator of caspase-9 and nuclear factor-kappaB. J. Biol. Chem. 274:1999;14560-14567.
51. Yoo N.J., Park W.S., Kim S.Y., Reed J.C., Son S.G., Lee J.Y., Lee S.H. Nod1, a CARD protein, enhances pro-interleukin-1beta processing through the interaction with pro-caspase-1. Biochem. Biophys. Res. Commun. 299:2002;652-658.
52. Hisamatsu T., Suzuki M., Reinecker H.C., Nadeau W.J., McCormick B.A., Podolsky D.K. CARD15/NOD2 functions as an antibacterial factor in human intestinal epithelial cells. Gastroenterology. 124:2003;993-1000 This paper reports the expression of Nod2 in epithelial intestinal cells and a role for Nod2 in conferring an antibacterial response against S. typhimurium.
53. Ogura Y., Lala S., Xin W., Smith E., Dowds T.A., Chen F.F., Zimmermann E., Tretiakova M., Cho J.H., Hart J.et al. Expression of NOD2 in Paneth cells: a possible link to Crohn's ileitis. Gut. 52:2003;1591-1597 This paper proposes a role for NOD2 in the regulation of Paneth cell mediated responses against intestinal bacteria, a mechanism to explain the link of NOD2 mutations to ileal disease.
54. Pauleau A.L., Murray P.J. Role of nod2 in the response of macrophages to toll-like receptor agonists. Mol. Cell. Biol. 23:2003;7531-7539.
55. Wolfert M.A., Murray T.F., Boons G.J., Moore J.N. The origin of the synergistic effect of muramyl dipeptide with endotoxin and peptidoglycan. J. Biol. Chem. 277:2002;39179-39186.
56. Liu B., Dai J., Zheng H., Stoilova D., Sun S., Li Z. Cell surface expression of an endoplasmic reticulum resident heat shock protein gp96 triggers MyD88-dependent systemic autoimmune diseases. Proc. Natl. Acad. Sci. USA. 100:2003;15824-15829.